Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is immature teratoma of the ovary?
Immature teratoma is a rare type of ovarian germ-cell cancer that arises from the egg cells of the ovary. Unlike a mature teratoma (the common, benign 'dermoid cyst'), an immature teratoma contains tissue that looks young and developing under the microscope — most importantly, immature nerve (neural) tissue, the amount of which determines the tumor's grade. It mainly affects girls and young women. Most are found while still confined to one ovary, and the outlook is excellent. Treatment is built around surgery that, whenever possible, removes only the affected ovary and tube so that fertility and hormones are preserved. Chemotherapy is added for higher-grade or more advanced tumors. A practical point unique to germ-cell tumors is that after chemotherapy, leftover masses sometimes contain only mature, benign tissue (a phenomenon called 'growing teratoma syndrome'), which is removed surgically rather than treated with more chemotherapy.
The main types
Doctors group immature teratoma of the ovary by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Grade 1 (low grade) | Only a small amount of immature tissue. Often cured by surgery alone, especially when confined to one ovary. |
| Grade 2–3 (higher grade) | More immature tissue, with a higher chance of spread; usually treated with surgery plus chemotherapy. |
| With yolk-sac or other germ-cell components (mixed) | Sometimes mixed with other germ-cell tumor types that raise tumor markers (like AFP); these are treated with chemotherapy in addition to surgery. |
| Growing teratoma syndrome | After chemotherapy, a mass may enlarge but turn out to be only mature, benign tissue; the treatment is surgical removal, not more chemotherapy. |
Staging, in plain terms
Immature teratomas use the FIGO ovarian staging system to describe spread, combined with the tumor's grade (how much immature tissue is present). Both stage and grade guide whether chemotherapy is added after surgery. Most are stage I.
| Ovarian cancer FIGO staging (with tumor grade) | What it generally means |
|---|---|
| Stage I | Confined to one or both ovaries. The most common situation; grade 1 tumors are often cured by surgery alone. |
| Stage II | Spread to other pelvic structures. Usually treated with surgery plus chemotherapy. |
| Stage III | Spread to the abdominal lining or lymph nodes. Treated with surgery and chemotherapy, with excellent cure rates for this tumor type. |
| Stage IV | Spread to distant organs. Uncommon; still highly treatable with combined therapy at an expert center. |
The standard of care
Immature Teratoma of the Ovary is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Fertility-sparing surgery
The cornerstone. For young patients with disease in one ovary, surgeons remove only the affected ovary and tube, preserving the uterus and other ovary and protecting fertility.
Chemotherapy (when needed)
Higher-grade or more advanced tumors are treated with a platinum-based regimen (commonly BEP — bleomycin, etoposide, cisplatin), which is highly effective for germ-cell cancers.
Surgery for residual masses
Leftover masses after chemotherapy are removed and examined; if they contain only mature, benign tissue (growing teratoma syndrome), surgery is the right treatment rather than more chemotherapy.
Tumor-marker and imaging follow-up
Blood markers (such as AFP and beta-hCG when present) and imaging are followed to confirm response and watch for recurrence.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide, while healthy cells repair themselves more effectively. For immature teratoma, radiation is essentially not used — surgery and chemotherapy cure the great majority of patients and spare fertility. If radiation were ever needed for an isolated resistant spot, it would be delivered as short, painless sessions that leave no radioactivity in your body.
The main ways radiation is delivered for immature teratoma of the ovary:
Radiation (essentially not used)
Radiation is not part of standard treatment for immature teratoma. Highly effective surgery and chemotherapy have replaced it, which also helps protect fertility in young patients.
Stereotactic / focused radiation (rare)
In the uncommon event of an isolated, chemotherapy-resistant deposit, precisely targeted radiation could be considered to control that single spot.
Palliative radiation (rare)
Short courses of radiation can relieve symptoms in the very rare case of advanced, treatment-resistant disease.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Less treatment for low-grade, early tumors: Studies, especially in children and young women, support surgery alone with close surveillance for stage I, grade 1 immature teratomas, sparing many patients the side effects of chemotherapy.[1]
Pediatric and gynecologic germ-cell tumor trials (2021–2025)
Recognizing growing teratoma syndrome: Better recognition that enlarging masses after chemotherapy may be benign mature tissue has shifted management toward surgical removal instead of additional chemotherapy.[2]
Germ-cell tumor management reviews (2020–2024)
Excellent long-term cure rates: Modern series report very high cure rates with surgery and, when needed, platinum-based chemotherapy, with strong attention to preserving fertility and long-term quality of life.[3]
Ovarian germ-cell tumor outcome studies (2022–2025)
Common questions
Can I still have children? Usually yes. Immature teratoma is typically treated with fertility-sparing surgery that removes only the affected ovary and tube, and the chemotherapy used (when needed) is generally compatible with future fertility. Your team can discuss fertility preservation options with you.
Is this the same as a dermoid cyst? No. A dermoid cyst (mature teratoma) is benign. An immature teratoma contains young, developing tissue and is a cancer — but it is highly curable, especially when found early.
Why might a mass grow during or after chemotherapy? Sometimes a teratoma's mature, benign tissue keeps growing even as the cancer is destroyed — this is called growing teratoma syndrome. It is not the cancer spreading; the right treatment is to remove the mass surgically and confirm it is benign.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Pediatric and gynecologic germ-cell tumor trials (2021–2025) (no indexed identifier — see your care team) ↩
- Germ-cell tumor management reviews (2020–2024) (no indexed identifier — see your care team) ↩
- Ovarian germ-cell tumor outcome studies (2022–2025) (no indexed identifier — see your care team) ↩